
Calidi Biotherapeutics, Inc.
CLDIHealthcare|Biotechnology|US
$0.70
+0.02 (+3.11%)
DCF Value
$9.22
Tangible Book / Share
$2.21
Cash / Share
$2.88
Next Earnings Report
Nov 17, 2026
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Sep 17, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
Oct 27, 2026 · GlobeNewsWire
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
Oct 19, 2026 · GlobeNewsWire
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency
Sep 25, 2026 · GlobeNewsWire
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
Sep 17, 2026 · GlobeNewsWire
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · GlobeNewsWire
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 13, 2026 · GlobeNewsWire
SEC Filings (91)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Sep 25, 2026 | 8-K | Material event | DocumentIndex |
| Sep 22, 2026 | 8-K | Material event | DocumentIndex |
| Sep 17, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| Jun 18, 2026 | 8-K | Material event | DocumentIndex |
| Jun 5, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 29, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| May 8, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 17, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Mar 27, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 27, 2026 | 8-K | Material event | DocumentIndex |
| Mar 11, 2026 | 8-K | Material event | DocumentIndex |
| Mar 9, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Mar 9, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 6, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 5, 2026 | S-3MEF | Shelf registration | DocumentIndex |
| Feb 10, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 10, 2026 | 8-K | Material event | DocumentIndex |
| Feb 4, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 29, 2026 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 10, 2025 | 8-K | Material event | DocumentIndex |
| Oct 31, 2025 | 8-K | Material event | DocumentIndex |
| Oct 24, 2025 | 8-K | Material event | DocumentIndex |
| Sep 19, 2025 | 8-K | Material event | DocumentIndex |
| Aug 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 27, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |